Status:

COMPLETED

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Lead Sponsor:

CSL Behring

Conditions:

Hereditary Angioedema Types I and II

Eligibility:

All Genders

12+ years

Phase:

PHASE4

Brief Summary

This is a prospective, international, multi-center, non-randomized, single arm, open-label, postmarketing study to investigate the formation of inhibitory anti-C1-INH antibodies in HAE subjects treate...

Eligibility Criteria

Inclusion

  • Diagnosis of congenital C1-INH deficiency (HAE type I or II) and assessed by the investigator to likely require intravenous (IV) Berinert treatment during the study period.
  • Male or female, ≥ 12 years of age at the time of signing informed consent.
  • Written informed consent for study participation obtained before undergoing any study specific procedures.

Exclusion

  • Incurable malignancies in the last 6 months prior to study entry.
  • Acquired angioedema due to C1-INH deficiency.
  • All other types of angioedema not associated with C1-INH deficiency.
  • Use of any C1-INH products other than Berinert within 30 days before the study, or planned use during the study.
  • Immunization within 30 days prior to study entry.
  • Autoimmune conditions requiring use of immunosuppressants during the study.
  • Known or suspected hypersensitivity to C1-INH.
  • Participation in any of the previous Berinert studies from which anti-C1-INH antibody results were submitted to the Food and Drug Administration.

Key Trial Info

Start Date :

November 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2014

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT01467947

Start Date

November 1 2011

End Date

October 1 2014

Last Update

February 6 2017

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

MHAT "Tsaritsa Yoanna"

Sofia, Bulgaria, 1504

2

Semmelweis University

Budapest, Hungary, 1125

3

Jagiellonian University

Krakow, Krakow, Poland, 31-531

4

Spitalul Clinic Judeţean Mureş,Secţia Clinică Medicină Internă,Compartimentul Alergologie şi Imunologie

Târgu-Mures, Mureș County, Romania, Cod 540103